{"slug":"semaglutide-diabetic-neuropathy","verification":{"valid":true,"entries":2,"head":"98cb17adb7a71d81b532339858dc2f43c8173f9ce50647d3ade65a960603b31c"},"energy":{"passes":2,"tokens_in":16773,"tokens_out":3181,"tokens_total":19954,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"98cb17adb7a71d81b532339858dc2f43c8173f9ce50647d3ade65a960603b31c"},"provenance":[{"ts":"2026-06-30T00:29:00.212Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Semaglutide for Diabetic Neuropathy\nSlug: semaglutide-diabetic-neuropathy\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_cross\",\"condition\":\"Diabetic neuropathy\",\"condition_key\":\"diabetic-neuropathy\",\"primary_peptide\":\"semaglutide\",\"peptides_in_scope\":[{\"id\":\"semaglutide\",\"name\":\"Semaglutide\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down if you have Diabetic neuropathy\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"semaglutide\",\"name\":\"Semaglutide\",\"section_title\":\"Why Semaglutide might help you\",\"layer\":\"metabolic load / body weight\",\"steps\":[\"You are reading about **Diabetic neuropathy** — what breaks down matters before any compound name.\",\"**What keeps failing:** Weight-related joint and disc overload; metabolic stress on repair capacity.\",\"**What Semaglutide is studied to do:** Studied for GLP-1-driven weight loss — reduces mechanical load on weight-sensitive tissues.\",\"**Therefore for you:** If that layer is part of your problem, Semaglutide is discussed because it targets repair (metabolic load / body weight) — not because it masks pain.\"],\"prose\":\"1. You are reading about **Diabetic neuropathy** — what breaks down matters before any compound name.\\n2. **What keeps failing:** Weight-related joint and disc overload; metabolic stress on repair capacity.\\n3. **What Semaglutide is studied to do:** Studied for GLP-1-driven weight loss — r","response":"{\n  \"slug\": \"semaglutide-diabetic-neuropathy\",\n  \"title\": \"Semaglutide for Diabetic Neuropathy: Metabolic Load and Repair Pathways\",\n  \"body\": \"## What's breaking down if you have Diabetic neuropathy\\n\\nDiabetic neuropathy develops when high blood sugar over time damages nerves, especially in the legs and feet. Degeneration shows up as pain, numbness, tingling, and reduced nerve conduction. Repair capacity falls behind because ongoing metabolic stress from elevated glucose and related inflammation keeps injuring nerve tissue and its supporting structures in the spinal cord and peripheral nerves.\\n\\nIf excess body weight is also present, it adds a layer of mechanical stress on weight-bearing tissues and can worsen overall metabolic strain. This combination makes it harder for natural repair processes to catch up.\\n\\n## Why Semaglutide might help you\\n\\n1. You are reading about **Diabetic neuropathy** — what breaks down matters before any compound name.\\n2. **What keeps failing:** Weight-related joint and disc overload; metabolic stress on repair capacity.\\n3. **What Semaglutide is studied to do:** Studied for GLP-1-driven weight loss — reduces mechanical load on weight-sensitive tissues.\\n4. **Therefore for you:** If that layer is part of your problem, Semaglutide is discussed because it targets repair (metabolic load / body weight) — not because it masks pain.\\n\\nIf your neuropathy involves extra body weight contributing to broader metabolic burden, semaglutide is examined for its effect on that specific layer. Weight loss of even 10–20 pounds can cut compressive forces on the lower back and legs by roughly 40–80 pounds during daily movement (mechanistic link from general GLP-1 weight-loss data). This lowers one source of ongoing tissue stress, potentially giving repair pathways more room to operate. Semaglutide’s primary studied action here is GLP-1 receptor activation leading to reduced appetite and caloric intake, not direct nerve numbing.\\n\\n## How these fit tog","tokens_in":16773,"tokens_out":3181,"cost":0,"prev":"genesis","hash":"2d682ff10c014117a3e6234a675a8fadf22ab4fd8b901b1225b02a8429a8df2a"},{"ts":"2026-07-17T02:41:44.673Z","model":"owner","action":"voxel_divide","prompt":"","input":"semaglutide-diabetic-neuropathy","response":"24 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"2d682ff10c014117a3e6234a675a8fadf22ab4fd8b901b1225b02a8429a8df2a","hash":"98cb17adb7a71d81b532339858dc2f43c8173f9ce50647d3ade65a960603b31c"}]}